Sign up
Forgot password?
FAQ: Login

Bawa Raj (ed.) Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data

  • pdf file
  • size 68,85 MB
  • added by
Bawa Raj (ed.) Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data
Jenny Stanford Publishing, 2022. — 158 p. — (Current Issues in Medicine. Volume 2). — ISBN: 978-981-4877-84-8.
The pace and sophistication of advances in medicine in the past two decades have necessitated a growing need for a comprehensive reference that highlights current issues in medicine. Each volume in the Current Issues in Medicine series is a stand‐alone text that provides a broad survey of various critical topics — all accomplished in a user-friendly yet interconnected format. The series not only highlights current advances but also explores related topics such as translational medicine, regulatory science, neglected diseases, global pandemics, patent law, immunotoxicology, theranostics, big data, artificial intelligence, novel imaging tools, combination drug products, and novel therapies. While bridging the gap between basic research and clinical medicine, this series provides a thorough understanding of medicine’s potential to address health problems from both the patient’s and the provider’s perspectives in a healthcare setting. The range of topics covered and the expertise of the contributing authors accurately reflect the rapidly evolving areas within medicine — from basic medical sciences to clinical specialties. Each volume is essential reading for physicians, medical students, nurses, fellows, residents, undergraduate and graduate students, educators, policymakers, and biomedical researchers. The multidisciplinary approach of the series makes it a valuable reference resource for the pharmaceutical industry, academia, and governments. However, unlike other series on medicine or medical textbooks, this series focuses on current trends, perspectives, and issues in medicine that are central to healthcare delivery in the 21st century. Volume 2 focuses on the current issues in basic medical sciences, subjects that are fundamental to the practice of medicine. Specifically, it discusses clinical immunology, medical microbiology, COVID-19, and big data. These subjects, traditionally taught in the first two years of medical school that precede clinical instruction, provide a core of basic knowledge critical to the success of clinical medicine during rotations, training, and medical practice.
SARS-CoV-2 and COVID-19: A Perspective.
Clinical Immunology
Specific Reactivity of Anti-Citrullinated Protein Antibodies to Citrullinated Peptides Associated with Rheumatoid Arthritis.
Complement Activation, Immunogenicity, and Immune Suppression as Potential Side Effects of Liposomes.
Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions.
Myelin Antigens and Antimyelin Antibodies.
Advances in the Understanding of the Inflammatory Milieu and Its Correlations with Neurological Disorders.
Role of Ligustrum in Allergic Disease.
Protective or Detrimental? The Role of Host Immunity in Leishmaniasis.
Intracellular Antibody Immunity and Its Applications.
Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries.
Medical Microbiology
Reflections on 40 Years of AIDS.
Formation and Maturation of the Oral Microbiota.
Could the Environment Affect the Mutation of the H1N1 Influenza Virus?
Current Perspectives in Medical MicrobiologyBacterial Virulence Plays a Crucial Role in Methicillin-Resistant S. aureus Sepsis.
Where Cancer and Bacteria Meet.
Fungal Diseases as Neglected Pathogens: A Wake-Up Call to Public Health Officials.
Catch the Wave: Metabolomic Analyzes in Human Pathogenic Fungi.
The Unmet Medical Need for Trypanosoma cruzi-Infected Patients: Monitoring the Disease Status.
Human Plague: An Old Scourge That Needs New Answers.
Biologics, Human Tissues, and Blood Products
Human Brain/Cloud Interface.
Artificial Intelligence in Drug Discovery: What Is New, and What Is Next?
Now the Future, We See Our Dreams: Artificial Intelligence in Drug Discovery.
Big Data and Artificial Intelligence Meet the COVID-19 Pandemic: Potential Applications and Promises.
Paradigm Shift in Medicinal Chemistry towards Data-Driven Approaches.
The Importance of Proper Statistical Methods in Developing Robust Predictive Models Using Chemodescriptors and Biodescriptors in the Twenty-First Century.
Fit-for-Purpose? — Challenges and Opportunities for Applications of Blockchain Technology in the Future of Healthcare.
mHealth Approach to Clinics in Rural Settings in Nutrition Counseling.
Ten Simple Rules for Engaging with Artificial Intelligence in Biomedicine.
Five Key Aspects of Metaproteomics as a Tool to Understand Functional Interactions in Host Associated Microbiomes.
Development and Use of FDA-approved Drugs for COVID-19
COVID-19: Hundred Questions and Answers for Healthcare Providers and the Public.
SARS-CoV-2 Tropism, Entry, Replication, and Propagation: Considerations for Drug Discovery and Development.
Presence of Antibody-Dependent Cellular Cytotoxicity against SARS-CoV-2 in COVID-19 Plasma.
Performance of SARS-CoV-2 Serology Tests: Are They Good Enough?
Forecasting the Novel Coronavirus COVID-19.
Pandemic Responses: Planning to Neutralize SARS-CoV-2 and Prepare for Future Outbreaks.
Pandemic Preparedness and Responses: WHO to Turn to in a Crisis?
Links between Integrin αvβ3 and COVID-19: Impact on Vascular and Thrombotic Risk.
  • Sign up or login using form at top of the page to download this file.
  • Sign up
Up